Two new diabetes drugs approved
May 28, 2015Sales and Marketing Japan, Takeda, diabetes in China, lilly
Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …
Eisai seeks new ALS drug approval
May 28, 2015Sales and Marketing Eisai, Japan, als, mecobalamin
Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …
Actavis and Valeant see FDA approval for IBS drugs
May 28, 2015Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells
Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
NICE sets out office for market access plans
May 28, 2015Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access
The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
Kayentis names four committee members
May 28, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis
French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans. Accepting director Guillaume …
Another Chinese health official arrested for corruption
May 27, 2015Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu
A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …
Novartis reveals ASCO plans
May 27, 2015Sales and Marketing ASCO, GSK, Novartis
Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …
Amgen cold sore virus drug shows ‘significant’ cancer benefit
May 27, 2015Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec
Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …
Eisai epilepsy drug sees EMA nod
May 27, 2015Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy
Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …
Sanofi appoints external affairs VP
May 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, suresh kumar
Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …
PrimeVigilance and Sound Opinion join forces
May 26, 2015acquisition, medical information, primevigilance
Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …
Sanofi prostate cancer drug to remain on CDF
May 26, 2015Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate
Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …
Otsuka, ViiV and AstraZeneca named in ABPI code complaints
May 26, 2015Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV
A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …
Amgen pulls out of psoriasis deal with AstraZeneca
May 26, 2015Sales and Marketing Amgen, AstraZeneca, psoriasis
Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …
Medicago invests big into plant-based vaccines
May 26, 2015Manufacturing and Production, Sales and Marketing Canada, Quebec, medicago, vaccines
Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …
GSK head joins Nabriva as chief medical officer
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elyse Seltzer, GSK, Nabriva Therapeutics
Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …
After the UK general election, what’s next for pharma?
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity
In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …
EMA recommends eight drugs for approval
May 22, 2015Sales and Marketing Amgen, BMS, EMA, Janssen, Merck, keytruda
The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha …
Bayer wins Cancer Drugs Fund appeal
May 22, 2015Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly
Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …
Sanofi’s rheumatoid arthritis biologic performs
May 22, 2015Sales and Marketing Sanofi, rheumatoid arthritis, sarilumab
French pharma giant Sanofi plans to submit its new rheumatoid arthritis biologic for regulatory approval in the US after it …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
